13F

KIDS ORTHOPEDIATRICS CORP

2026Q1 · CUSIP 68752L100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
118
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
61
Δ whales
+3
Inst. holding value
$254M
New positions
18
Closed positions
17
Price momentum (1Q)
+6.4%
Put / Call
1/1

Breadth history (34 quarters)

2018Q1: Δ-1 · h=47 2018Q2: Δ+7 · h=54 2018Q3: Δ+8 · h=62 2018Q4: Δ+12 · h=74 2019Q1: Δ+17 · h=91 2019Q2: Δ+6 · h=97 2019Q3: Δ-11 · h=86 2019Q4: Δ+18 · h=104 2020Q1: Δ-1 · h=103 2020Q2: Δ+22 · h=125 2020Q3: Δ-6 · h=119 2020Q4: Δ+10 · h=129 2021Q1: Δ-9 · h=120 2021Q2: Δ+12 · h=132 2021Q3: Δ+6 · h=138 2021Q4: Δ-11 · h=127 2022Q1: Δ-2 · h=125 2022Q2: Δ-11 · h=114 2022Q3: Δ+11 · h=125 2022Q4: Δ-8 · h=117 2023Q1: Δ+2 · h=119 2023Q2: Δ-2 · h=117 2023Q3: Δ-2 · h=115 2023Q4: Δ+13 · h=128 2024Q1: Δ-9 · h=119 2024Q2: Δ+2 · h=121 2024Q3: Δ+2 · h=123 2024Q4: Δ-15 · h=108 2025Q1: Δ+6 · h=114 2025Q2: Δ+1 · h=115 2025Q3: Δ-6 · h=109 2025Q4: Δ+8 · h=117 2026Q1: Δ+1 · h=118 2018Q1: holders=47 2018Q2: holders=54 2018Q3: holders=62 2018Q4: holders=74 2019Q1: holders=91 2019Q2: holders=97 2019Q3: holders=86 2019Q4: holders=104 2020Q1: holders=103 2020Q2: holders=125 2020Q3: holders=119 2020Q4: holders=129 2021Q1: holders=120 2021Q2: holders=132 2021Q3: holders=138 2021Q4: holders=127 2022Q1: holders=125 2022Q2: holders=114 2022Q3: holders=125 2022Q4: holders=117 2023Q1: holders=119 2023Q2: holders=117 2023Q3: holders=115 2023Q4: holders=128 2024Q1: holders=119 2024Q2: holders=121 2024Q3: holders=123 2024Q4: holders=108 2025Q1: holders=114 2025Q2: holders=115 2025Q3: holders=109 2025Q4: holders=117 2026Q1: holders=118 -22 -11 +0 +11 +22 4294145 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q3 Top 12% +2.0% +2.9%
2020Q2 Top 16% -11.9% -2.4%
2019Q1 Top 17% -21.2% -3.8%
2018Q4 Top 19% +7.5% -13.7%

Options Sentiment

Put holders
1
QoQ: +1
Call holders
1
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.68
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+14.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $33M 2022-09-30: $35M 2022-12-31: $31M 2023-03-31: $32M 2023-06-30: $40M 2023-09-30: $40M 2023-12-31: $38M 2024-03-31: $45M 2024-06-30: $53M 2024-09-30: $55M 2024-12-31: $53M 2025-03-31: $52M 2025-06-30: $61M 2025-09-30: $61M 2025-12-31: $62M 2026-03-31: $59M 2022-06-30: EPS -0.02 2022-09-30: EPS 0.87 2022-12-31: EPS -0.32 2023-03-31: EPS -0.30 2023-06-30: EPS -0.13 2023-09-30: EPS -0.20 2023-12-31: EPS -0.29 2024-03-31: EPS -0.34 2024-06-30: EPS -0.26 2024-09-30: EPS -0.34 2024-12-31: EPS -0.70 2025-03-31: EPS -0.46 2025-06-30: EPS -0.30 2025-09-30: EPS -0.50 2025-12-31: EPS -0.43 2026-03-31: EPS -0.45 0M 31M 62M $M -0.77 0.09 0.96 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 320 2023-03-31: PE 198.82023-06-30: PE 319.6 179 257 336 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)